|Forum - Wall Street Pit
||Stock Due Diligence for All|
|From: trendtn (Rep: 169)||Date: 11/19/2019 11:48|
|Forum: Wall Street Pit - Msg #2805394||Thread #674108485 (Rec: 0) |
Crsp reported early data on a trial...just two patients.
One with beta thass. The other with sickle cell.
Both patients faced several crises...but both at least nine months in appear to have been cured.
Both these diseases are genetic...passed on from parents to child for generations.
Both of these diseases are ...or perhaps were incurable.
Crsp is of course up on this stunning very early news. It's really historic news.
Two diseases that have haunted mankind for centuries may be finished...not only for these two patients ...but also for all of their descendants.
I believe that all the crispr stocks will be bought. As a group they are undervalued. Crsp edit ntla...and forgotten today clls...all much higher... investment s
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 2020- TheLion.com, Inc.